investigational treatments | sciencenewsnet.in

Breaking News

Kansas Proving Grounds Partners with SkyScoutAI Innovations Inc. to Deploy AI-Powered Drones for Wildfire Solution at America’s First Carbon Neutral Industrial Park

Perinatal Transmission of HIV Can Lead to Cognitive Deficits

CSUF Grad from Zimbabwe Aims to Improve Access to Mental Health Services

Alzheimer’s Consortium set to bring experts and families together at ASU

Critical Minerals Recovery from Electronic Waste

The Pediatric Emergency Department at Joseph M. Sanzari Children’s Hospital Becomes the First Autism Certified Center in the State

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

Landmark Conference Celebrating Betty Ford’s Legacy as First Lady, With Notable Expert Panels

New study points to racial and social barriers that block treatment for multiple myeloma

Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan

24 Apr, 2024

University Hospitals Announces its Participation in Novel Clinical Trial Testing Multiple Therapeutics to Treat COVID-19

November 5, 2020 sarah JonasAnnouncement

ACTIV-2 will evaluate the safety and efficacy of investigational treatments for adults who have COVID-19, but do not require hospitalization. ACTIV-2 is a randomized, blinded, controlled study that tests a variety of new agents against placebo. This approach allows promising investigational agents to be added and removed over the course of the study.